Game-changing medical device technology addressing uncontrollable torso hemorrhage - preventing 120,000+ preventable deaths annually
Too many people die from uncontrollable torso hemorrhage - these are preventable deaths that demand action
Patients are bleeding out and dying from uncontrollable torso hemorrhage. No procedure currently exists to stem bleeding from Non-Compressible Torso Hemorrhages (NCTH) outside the hospital.
Loss of life is not due to the injury but to the loss of blood.
"I see far too many young women & young men die from what are survivable injuries. Patients tragically bleed out from undiagnosed—but treatable—torso hemorrhage, dying from survivable injuries despite modern medicine's capabilities. This is an unacceptable failure we're solving."
- Professor Benjamin Starnes MD, Ontogo Vascular
OV-Control™ – Advancing aortic occlusion with single-step, problem-free deployment and migration resistance, delivering rapid hemorrhage control when every second counts.
OV-Control™ redefines speed and stability in aortic occlusion setting a new standard where others fall short.
Seeking funding to bring OV-Control™ to market and save lives
Clear regulatory pathway via FDA 510(k) clearance. Proof of concept to in-market product in just 2 years.
Patents protecting key value drivers, including critical 14Fr specification that prevents competitors from using optimal catheter dimensions.
Direct sales model driving positive Year 4 cashflow. Future growth funded through cashflow and/or debt.
Existing coding within hospitals. Life-saving devices receive premium consideration from CMS and commercial payers.
42% of surgeons now believe aortic occlusion is a valid solution. Clinical opinion is shifting in our favor.
250+ years of collective experience in MedTech. Proven track record of building successful vascular businesses.
Our team brings deep expertise—every member is a seasoned health and medical device professional, collectively delivering 250+ years of proven experience
Inventor of OV-Control™, world-renowned vascular surgeon with military and civilian trauma experience. 15-year U.S. Army veteran, former Head of Vascular Surgery at UW/Harborview Medical Center.
Extensive commercialization experience in vascular medical devices. Proven track record in building and scaling medical technology businesses globally.
Proven leadership in scaling MedTech operations with deep expertise in vascular technology commercialization and strategic business development.
Strategic business development expertise with extensive experience in HealthTech startup operations and corporate governance.
Veteran medical device sales executive with five decades of experience building and managing exceptional sales teams across global markets.
Product development and engineering leader with extensive experience taking MedTech innovations from concept to commercial success.
Growth-focused sales leader with deep expertise in vascular medical device markets and proven ability to drive revenue expansion.
Experienced COO with extensive MedTech vascular business operations expertise ready to join our team.
"The Day Before Something Is Truly A Breakthrough, It's A Crazy Idea!"
Ready to invest in life-saving innovation? Contact us to learn more about this transformative opportunity.